To the Editor:

Spine Journal

Volumn 7, Issue 4, 2007, Pages 509-510

  Tumialán, Luis M ^a   Rodts, Gerald E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTHRODESIS; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DYSPHAGIA; HUMAN; INFLAMMATION; INTERVERTEBRAL DISKECTOMY; LETTER; OSTEOSYNTHESIS; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SPINE FUSION; SPINE RADIOGRAPHY; CERVICAL SPINE; EDEMA; METHODOLOGY; NOTE;

BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; DISKECTOMY; EDEMA; HUMANS; RECOMBINANT PROTEINS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 34447257902     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spinee.2007.03.005     Document Type: Letter

References (4)

1. Perri B., Cooper M., Lauryssen C., and Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: a case study. Spine J 7 (2007) 235-239
2. Shields L.B., Raque G.H., Glassman S.D., et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 31 (2006) 542-547
3. Smucker J.D., Rhee J.M., Singh K., Yoon S.T., and Heller J.G. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 31 (2006) 2813-2819
4. Tumialan LM, Pan J, Rodts GE, Mummaneni PV. The safety and efficacy of anterior cervical discectomy and fusion with polyetheretherketone spacer and recombinant human bone morphogenetic protein: a review of 200 patients, in press.